Renovia, a women-led company that develops digital therapeutics for female pelvic floor disorders, today announced the appointment of Eileen Maus in Q4 2020 as the company’s president and CEO. Under her leadership, Renovia completed patient enrollment in its all-virtual randomized control trial (RCT) for the leva Digital Therapeutic one month ahead of schedule. Ms. Maus is an accomplished leader in women’s health and has directed the success…
![](https://femtechinsider.com/wp-content/uploads/2021/01/renovia-1000x658.jpg)